M.C. Pastor

674 total citations
26 papers, 482 citations indexed

About

M.C. Pastor is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, M.C. Pastor has authored 26 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Oncology. Recurrent topics in M.C. Pastor's work include Renal Transplantation Outcomes and Treatments (4 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Heart Failure Treatment and Management (3 papers). M.C. Pastor is often cited by papers focused on Renal Transplantation Outcomes and Treatments (4 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Heart Failure Treatment and Management (3 papers). M.C. Pastor collaborates with scholars based in Spain, United States and Australia. M.C. Pastor's co-authors include F.-Javier Gella, Joaquı́n Arenas, R. Romero, María Luisa Granada, Ricardo Lauzurica, Anna Sanmartı́, Jaume Barallat, I. Salinas, Antoni Bayés‐Genís and Josep Lupón and has published in prestigious journals such as The Lancet, PLoS ONE and Diabetes Care.

In The Last Decade

M.C. Pastor

25 papers receiving 458 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.C. Pastor Spain 13 90 90 75 68 67 26 482
Fatih Oğuz Türkiye 14 110 1.2× 50 0.6× 72 1.0× 49 0.7× 75 1.1× 42 638
Elisabetta Rizzoli Italy 15 85 0.9× 112 1.2× 92 1.2× 64 0.9× 74 1.1× 32 618
Ali Beytur Türkiye 17 68 0.8× 51 0.6× 69 0.9× 77 1.1× 92 1.4× 48 783
Gifford Lum United States 12 89 1.0× 94 1.0× 65 0.9× 33 0.5× 87 1.3× 38 601
Gülsüm Özkan Türkiye 13 101 1.1× 44 0.5× 102 1.4× 30 0.4× 99 1.5× 54 545
Wan Nazaimoon Wan Mohamud Malaysia 16 67 0.7× 226 2.5× 82 1.1× 39 0.6× 109 1.6× 25 600
Mitsutaka Kanamaru Japan 15 159 1.8× 79 0.9× 100 1.3× 42 0.6× 140 2.1× 44 698
Özge Tuğçe Paşaoğlu Türkiye 14 51 0.6× 64 0.7× 114 1.5× 31 0.5× 75 1.1× 44 594
Aparna R. Bitla India 13 42 0.5× 94 1.0× 67 0.9× 20 0.3× 129 1.9× 51 517
İdris Mehmetoğlu Türkiye 14 72 0.8× 34 0.4× 44 0.6× 42 0.6× 86 1.3× 37 497

Countries citing papers authored by M.C. Pastor

Since Specialization
Citations

This map shows the geographic impact of M.C. Pastor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.C. Pastor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.C. Pastor more than expected).

Fields of papers citing papers by M.C. Pastor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.C. Pastor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.C. Pastor. The network helps show where M.C. Pastor may publish in the future.

Co-authorship network of co-authors of M.C. Pastor

This figure shows the co-authorship network connecting the top 25 collaborators of M.C. Pastor. A scholar is included among the top collaborators of M.C. Pastor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.C. Pastor. M.C. Pastor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pacho, Cristina, Mar Domingo, Josep Lupón, et al.. (2018). Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patients. BMC Geriatrics. 18(1). 109–109. 33 indexed citations
2.
Bayés‐Genís, Antoni, Jaume Barallat, Marta de Antonio, et al.. (2017). Bloodstream Amyloid-beta (1-40) Peptide, Cognition, and Outcomes in Heart Failure. Revista Española de Cardiología (English Edition). 70(11). 924–932. 20 indexed citations
3.
Iglesias, Eva, M.C. Pastor, Jaume Barallat, et al.. (2016). Inflammation and oxidation: do they improve after kidney transplantation? Relationship with mortality after transplantation. International Urology and Nephrology. 49(3). 533–540. 7 indexed citations
4.
Barallat, Jaume, et al.. (2015). Sodium interference in the determination of urinary aldosterone. Clinical Biochemistry. 49(3). 295–297. 6 indexed citations
5.
Ibernón, Meritxell, Dolores López, M.C. Pastor, et al.. (2014). Urinary Peptide Profiling to Differentiate between Minimal Change Disease and Focal Segmental Glomerulosclerosis. PLoS ONE. 9(1). e87731–e87731. 20 indexed citations
6.
Lauzurica, Ricardo, et al.. (2013). Magnetic bead-based proteomic technology to study paricalcitol effect in kidney transplant recipients. European Journal of Pharmacology. 709(1-3). 72–79. 11 indexed citations
7.
Sánchez, Anna, et al.. (2010). Effect of Paricalcitol on the Urinary Peptidome of Kidney Transplant Patients. Transplantation Proceedings. 42(8). 2924–2927. 14 indexed citations
8.
Pellitero, Sílvia, Jordi L. Reverter, Eduarda Pizarro, et al.. (2009). Association of the IGF1/pregnancy-associated plasma protein-A system and adipocytokine levels with the presence and the morphology of carotid plaques in type 2 diabetes mellitus patients with stable glycaemic control. European Journal of Endocrinology. 160(6). 925–932. 14 indexed citations
9.
Bayés, Beatriu, Ricardo Lauzurica, M.C. Pastor, et al.. (2009). Effect of Low Doses of Atorvastatin on the Urinary Peptide Profile of Kidney Transplant Patients. Transplantation Proceedings. 41(6). 2111–2114. 9 indexed citations
10.
Morales‐Indiano, Cristian, Ricardo Lauzurica, M.C. Pastor, et al.. (2009). Greater Posttransplant Inflammation and Oxidation Are Associated With Worsening Kidney Function in Patients With Pretransplant Diabetes Mellitus. Transplantation Proceedings. 41(6). 2126–2128. 10 indexed citations
11.
Aguilera, Eva, María Luisa Granada, M.C. Pastor, et al.. (2008). Effects of GH treatment in GH-deficient adults on adiponectin, leptin and pregnancy-associated plasma protein-A.. European Journal of Endocrinology. 158(4). 483–490. 35 indexed citations
12.
Bayés, Beatriz, M.C. Pastor, Ricardo Lauzurica, et al.. (2007). Do Anti-CD25 Monoclonal Antibodies Potentiate Posttransplant Diabetes Mellitus?. Transplantation Proceedings. 39(7). 2248–2250. 14 indexed citations
13.
Lauzurica, Ricardo, M.C. Pastor, Beatriz Bayés, et al.. (2007). Subclinical Inflammation in Renal Transplant Recipients: Impact of Cyclosporine Microemulsion Versus Tacrolimus. Transplantation Proceedings. 39(7). 2170–2172. 5 indexed citations
14.
Bayés, Beatriu, M.C. Pastor, Ricardo Lauzurica, et al.. (2002). Apolipoprotein E alleles, dyslipemia and kidney transplantation. Transplantation Proceedings. 34(1). 373–373. 6 indexed citations
15.
16.
Pastor, M.C., et al.. (1993). Serum and Erythrocyte Tocopherol in Uremic Patients: Effect of Hemodialysis versus Peritoneal Dialysis. American Journal of Nephrology. 13(4). 238–243. 35 indexed citations
17.
Sierra, Cristina, et al.. (1992). Liquid chromatography determination of α-tocopherol in erythrocytes. Clinica Chimica Acta. 208(1-2). 119–126. 19 indexed citations
18.
Abad, Albert, Rafael Rosell, M.C. Pastor, et al.. (1991). Sequential Combination of Methotrexate (MTX), 5-Fluorouracil (FU), and High-Dose Folinic Acid (FA) in Advanced Colorectal Cancer. American Journal of Clinical Oncology. 14(5). 393–396. 9 indexed citations
19.
Shaldon, Stanley, K. M. Koch, Charles A. Dinarello, et al.. (1987). β2-MICROGLOBULIN AND HAEMODIALYSIS. The Lancet. 329(8538). 925–927. 21 indexed citations
20.
Gella, F.-Javier, et al.. (1985). A simple procedure for the routine determination of aspartate aminotransferase and alanine aminotransferase with pyridoxal phosphate. Clinica Chimica Acta. 153(3). 241–247. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fatih Oğuz Breakdown of academic impact, for papers by Elisabetta Rizzoli Breakdown of academic impact, for papers by Ali Beytur Breakdown of academic impact, for papers by Gifford Lum Breakdown of academic impact, for papers by Gülsüm Özkan Breakdown of academic impact, for papers by Wan Nazaimoon Wan Mohamud Breakdown of academic impact, for papers by Mitsutaka Kanamaru Breakdown of academic impact, for papers by Özge Tuğçe Paşaoğlu Breakdown of academic impact, for papers by Aparna R. Bitla Breakdown of academic impact, for papers by İdris Mehmetoğlu
Rankless by CCL
2026